The study predicts the short term and long term trends that can shape up the future of the Point of Care (PoC) Molecular Diagnostics market including the COVID-19 pandemic implications for Point of Care (PoC) Molecular Diagnostics industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.
The Point of Care (PoC) Molecular Diagnostics market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Point of Care (PoC) Molecular Diagnostics Companies are focusing on improving efficiency and containing costs in current economically challenging conditions. Point of Care (PoC) Molecular Diagnostics market forecast and Point of Care (PoC) Molecular Diagnostics market growth is outlook through 2030.
The report reflects on predictions with 2022 as the base year and 2023-2030 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Point of Care (PoC) Molecular Diagnostics market opportunities, underlying market factors, demographic and economic factors, market developments and others.
Point of Care (PoC) Molecular Diagnostics industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Point of Care (PoC) Molecular Diagnostics market share in developed countries.
This product will be delivered within 1-3 business days.
The Point of Care (PoC) Molecular Diagnostics market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Point of Care (PoC) Molecular Diagnostics Companies are focusing on improving efficiency and containing costs in current economically challenging conditions. Point of Care (PoC) Molecular Diagnostics market forecast and Point of Care (PoC) Molecular Diagnostics market growth is outlook through 2030.
The report reflects on predictions with 2022 as the base year and 2023-2030 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Point of Care (PoC) Molecular Diagnostics market opportunities, underlying market factors, demographic and economic factors, market developments and others.
Point of Care (PoC) Molecular Diagnostics industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Point of Care (PoC) Molecular Diagnostics market share in developed countries.
Scope of the research
Global Point of Care (PoC) Molecular Diagnostics Market is analyzed and forecast over the outlook period from 2023 to 2030 By application including
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Others
Global Point of Care (PoC) Molecular Diagnostics Market is analyzed and forecast over the outlook period from 2023 to 2030 By technology including
- PCR Based
- Genetic Sequencing Based
- Hybridization Based
- Microarray Based
Global Point of Care (PoC) Molecular Diagnostics Market is analyzed and forecast over the outlook period from 2023 to 2030 By End User including
- Laboratories
- Hospitals
- Homecare
- Others
This product will be delivered within 1-3 business days.
Table of Contents
1. Table of Contents
2. Executive Summary
3. Strategic Imperatives on Global Point of Care (PoC) Molecular Diagnostics Market
4. Global Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2030 Outlook by Application
5. Global Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2030 Outlook by Technology
6. Global Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2030 Outlook by End User
7 Asia Pacific Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2030
8 Europe Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2030
9 North America Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2030
10 South and Central America Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2030
11 Middle East Africa Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2030
12 Business Profiles of Leading Companies
14 Appendix
Companies Mentioned
- Abaxis
- Abbott Laboratories
- Alere Inc
- Bayer Healthcare
- Biomerieux
- Bio-Rad Laboratories
- Dako
- Danaher Corporation
- Nipro Diagnostics
- Nova Biomedical
Methodology
LOADING...